LifeStance Health Group, Inc.
LFST
$7.59
-$0.29-3.68%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 15.99% | 18.95% | 20.32% | 18.94% | 22.34% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.99% | 18.95% | 20.32% | 18.94% | 22.34% |
| Cost of Revenue | 9.51% | 13.72% | 14.96% | 12.42% | 18.37% |
| Gross Profit | 31.35% | 31.78% | 34.03% | 36.10% | 32.89% |
| SG&A Expenses | 11.00% | 1.90% | -1.07% | 5.11% | -3.69% |
| Depreciation & Amortization | -33.96% | -22.97% | -4.76% | 18.33% | 17.63% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.74% | 7.83% | 8.59% | 10.66% | 11.27% |
| Operating Income | 106.72% | 101.51% | 63.14% | 50.93% | 47.26% |
| Income Before Tax | 76.83% | 93.10% | 56.51% | 45.83% | 28.67% |
| Income Tax Expenses | -126.55% | 103.51% | 110.03% | 108.99% | 194.09% |
| Earnings from Continuing Operations | 84.18% | 90.33% | 48.82% | 38.39% | 3.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 84.18% | 90.33% | 48.82% | 38.39% | 3.64% |
| EBIT | 106.72% | 101.51% | 63.14% | 50.93% | 47.26% |
| EBITDA | 2,508.47% | 318.13% | 112.91% | 139.47% | 97.25% |
| EPS Basic | 84.72% | 90.50% | 51.04% | 40.89% | 6.78% |
| Normalized Basic EPS | 72.31% | 84.84% | 56.78% | 44.46% | 43.46% |
| EPS Diluted | 84.72% | 90.50% | 51.04% | 40.89% | 6.78% |
| Normalized Diluted EPS | 72.31% | 84.84% | 56.78% | 44.46% | 43.46% |
| Average Basic Shares Outstanding | 3.54% | 2.12% | 4.48% | 4.28% | 3.43% |
| Average Diluted Shares Outstanding | 3.54% | 2.12% | 4.48% | 4.28% | 3.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
